Prashant Kohli
Chief Executive Officer at ACASTI PHARMA INC.
Net worth: 73 148 $ as of 2024-03-30
Profile
Prashant Kohli is currently the Chief Executive Officer & Director at Acasti Pharma, Inc. He previously worked as the Vice President-Commercial Operations at Grace Therapeutics LLC.
Mr. Kohli completed his undergraduate degree at Augustana College (Illinois) and holds undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-18 | 21,357 ( 0.23% ) | 73 148 $ | 2024-03-30 |
Prashant Kohli active positions
| Companies | Position | Start |
|---|---|---|
| ACASTI PHARMA INC. | Chief Executive Officer | 2023-04-03 |
Former positions of Prashant Kohli
| Companies | Position | End |
|---|---|---|
Grace Therapeutics LLC
 Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Corporate Officer/Principal | 2021-07-31 |
Training of Prashant Kohli
| Augustana College (Illinois) | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |
- Stock Market
- Insiders
- Prashant Kohli
